[go: up one dir, main page]

MXPA04001878A - Medicinal compositions containing angiotensin ii receptor antagonist. - Google Patents

Medicinal compositions containing angiotensin ii receptor antagonist.

Info

Publication number
MXPA04001878A
MXPA04001878A MXPA04001878A MXPA04001878A MXPA04001878A MX PA04001878 A MXPA04001878 A MX PA04001878A MX PA04001878 A MXPA04001878 A MX PA04001878A MX PA04001878 A MXPA04001878 A MX PA04001878A MX PA04001878 A MXPA04001878 A MX PA04001878A
Authority
MX
Mexico
Prior art keywords
receptor antagonist
medicinal compositions
compositions containing
containing angiotensin
angiotensin
Prior art date
Application number
MXPA04001878A
Other languages
Spanish (es)
Inventor
Sada Toshio
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of MXPA04001878A publication Critical patent/MXPA04001878A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Medicinal compositions for administering an angiotensin II receptor antagonist and an ACAT inhibitor either at the same time or separately at a certain interval.
MXPA04001878A 2001-08-28 2002-08-27 Medicinal compositions containing angiotensin ii receptor antagonist. MXPA04001878A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001257435 2001-08-28
PCT/JP2002/008629 WO2003020315A1 (en) 2001-08-28 2002-08-27 Medicinal compositions containing angiotensin ii receptor antagonist

Publications (1)

Publication Number Publication Date
MXPA04001878A true MXPA04001878A (en) 2004-06-15

Family

ID=19085097

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04001878A MXPA04001878A (en) 2001-08-28 2002-08-27 Medicinal compositions containing angiotensin ii receptor antagonist.

Country Status (17)

Country Link
US (1) US20040198788A1 (en)
EP (1) EP1421953A4 (en)
KR (1) KR20040032969A (en)
CN (1) CN1589154A (en)
AU (1) AU2002328569B9 (en)
BR (1) BR0212254A (en)
CA (1) CA2459017A1 (en)
CO (1) CO5560583A2 (en)
HU (1) HUP0401696A2 (en)
IL (1) IL160438A0 (en)
MX (1) MXPA04001878A (en)
NO (1) NO20041291L (en)
NZ (1) NZ531346A (en)
PL (1) PL368843A1 (en)
RU (1) RU2004105965A (en)
WO (1) WO2003020315A1 (en)
ZA (1) ZA200401603B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1604664A4 (en) * 2003-01-31 2006-12-27 Sankyo Co MEDICINE FOR THE PREVENTION AND TREATMENT OF ARTERIOSCLEROSIS AND HYPERTENSION
US20090226420A1 (en) * 2005-11-10 2009-09-10 Elizabeth Hauser Methods of Determining the Risk of Developing Coronary Artery Disease
KR101345876B1 (en) * 2012-01-31 2013-12-30 인제대학교 산학협력단 Composition for preserving cells, tissue or organs containing Fimasartan
CN112979617A (en) * 2019-12-17 2021-06-18 中国科学院苏州纳米技术与纳米仿生研究所 Irbesartan piperazine salt and preparation method and application thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771072A (en) * 1985-01-10 1988-09-13 Tanabe Seiyaku Co., Ltd. Alkoxynaphthalene derivatives
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
EP0421441B1 (en) * 1989-10-06 1995-01-25 Fujirebio Inc. Pantothenic acid derivatives
DE122007000050I1 (en) * 1990-02-19 2007-11-08 Novartis Ag acyl compounds
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
GB9025509D0 (en) * 1990-11-23 1991-01-09 Fujisawa Pharmaceutical Co New amide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
JP2650096B2 (en) * 1990-11-26 1997-09-03 大正製薬株式会社 Anilide derivative
US5591762A (en) * 1991-02-06 1997-01-07 Dr. Karl Thomae Gmbh Benzimidazoles useful as angiotensin-11 antagonists
CA2229000C (en) * 1991-02-21 2002-04-09 Sankyo Company, Limited 1-biphenylimidazole derivatives, their preparation and their therapeutic use
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
JP3720395B2 (en) * 1994-09-20 2005-11-24 京都薬品工業株式会社 Novel heterocyclic derivative, production method thereof and pharmaceutical use thereof
DK0866059T3 (en) * 1995-10-05 2002-03-25 Kyoto Pharma Ind New heterocyclic derivatives and their medical use
FR2741619B1 (en) * 1995-11-28 1998-02-13 Pf Medicament NOVEL 2,3,5-TRIMETHYL-4-HYDROXY-ANILIDES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
CA2197364A1 (en) * 1996-02-15 1997-08-16 Toshikazu Suzuki Phenol compound and process for preparing the same
JPH11228416A (en) * 1997-10-23 1999-08-24 Takeda Chem Ind Ltd Lipid reducing
US6221897B1 (en) * 1998-06-10 2001-04-24 Aventis Pharma Deutschland Gmbh Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
DE19916108C1 (en) * 1999-04-09 2001-01-11 Aventis Pharma Gmbh 1,4-Benzothiazepine-1,1-dioxide derivatives substituted with sugar residues, process for their preparation and their use
EP1382336B1 (en) * 2001-04-25 2010-09-08 Takeda Pharmaceutical Company Limited Use of the abc expression promotor pioglitazone for the treatment of arteriosclerosis obliterans

Also Published As

Publication number Publication date
AU2002328569B2 (en) 2005-09-22
HUP0401696A2 (en) 2004-11-29
IL160438A0 (en) 2004-07-25
KR20040032969A (en) 2004-04-17
NO20041291L (en) 2004-05-27
ZA200401603B (en) 2004-10-19
BR0212254A (en) 2004-10-19
NO20041291D0 (en) 2004-03-26
WO2003020315A1 (en) 2003-03-13
CN1589154A (en) 2005-03-02
AU2002328569B9 (en) 2005-10-27
PL368843A1 (en) 2005-04-04
NZ531346A (en) 2005-10-28
EP1421953A4 (en) 2004-09-15
CA2459017A1 (en) 2003-03-13
EP1421953A1 (en) 2004-05-26
RU2004105965A (en) 2005-05-10
CO5560583A2 (en) 2005-09-30
US20040198788A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
AU9393601A (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
AU3652102A (en) Compounds and their uses
DE60112974D1 (en) Carbolinderivate
TW200505509A (en) Tamper resistant transdermal dosage form
CY1108725T1 (en) Combination of NMDA antagonist and acetylcholinesterase inhibitors for the treatment of ALZHEIMER
IL159022A0 (en) Hv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
MXPA04000586A (en) Combination of an aldosterone receptor antagonist and an hmg coa reductase inhibitor.
EP2258381A3 (en) Ghrelin analogs
DE60216233D1 (en) Carbolinderivate
GB0002336D0 (en) Medicaments
RS97604A (en) New etonogestrel esters
ATE266420T1 (en) COMBINATION PREPARATION CONTAINING SELECTIVE NMDA NR2B ANTAGONISTS AND COX-2 INHIBITORS
MY137620A (en) Therapeutic treatment
ZA200305803B (en) Prevention of diabetes by administration of GnRH antagonists.
IL145645A0 (en) N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
MXPA04001878A (en) Medicinal compositions containing angiotensin ii receptor antagonist.
PL369736A1 (en) New medicinal compositions on the basis of anticholinergic agents and egfr kinase inhibitors
IL166312A0 (en) A pharmaceutical composition containing an adp receptor antagonist and an acat inhibitor
MXPA03008051A (en) Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists.
AU2002258437A1 (en) Peptide deformylase inhibitors
AU2002328569A1 (en) Medicinal compositions containing angiotensin II receptor antagonist
PL359727A1 (en) Crystalline pharmaceutical
GB0124844D0 (en) Report generating system
MXPA04005226A (en) 1,3-diarylprop-2-en-1-ones, compositions containing same and use thereof.
MY137953A (en) New association of an anti-atherothrombotic agent and an anti-platelet-aggregation agent